Covered recipient · General Payments record
SHIRLEY S PRITCHETT
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$4,787.93
- Reported across 247 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $380.90 | 15 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $164.28 | 5 |
| Organon LLC | $135.10 | 3 |
| MILLICENT US INC | $92.52 | 4 |
| Exeltis, USA Inc. | $39.38 | 2 |
| MAYNE PHARMA COMMERCIAL LLC | $29.73 | 1 |
| PFIZER INC. | $18.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $18.25 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139286394 | CMS |
| Astellas Pharma US Inc | $14.63 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139275192 | CMS |
| Astellas Pharma US Inc | $18.47 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139374807 | CMS |
| Astellas Pharma US Inc | $99.00 | 09/19/2024 | Education | Undisputed | 01/23/2026 | 1139408477 | CMS |
| Astellas Pharma US Inc | $13.93 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139420793 | CMS |
| Exeltis, USA Inc. | $18.28 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150002454 | CMS |
| Exeltis, USA Inc. | $21.10 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150002456 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $29.73 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154692713 | CMS |
| MILLICENT US INC | $23.68 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150911126 | CMS |
| MILLICENT US INC | $24.02 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150911128 | CMS |
| MILLICENT US INC | $23.93 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150911130 | CMS |
| MILLICENT US INC | $20.89 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150911132 | CMS |
| Organon Llc | $37.50 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136238507 | CMS |
| Organon Llc | $81.17 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136238510 | CMS |
| Organon Llc | $16.43 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136238514 | CMS |
| PFIZER INC. | $18.89 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131507605 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.